Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells
- 2 March 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (5), 827-837
- https://doi.org/10.1016/0006-2952(94)90483-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Noncovalent drug-DNA binding interactions that inhibit and stimulate (A)BC excinucleaseBiochemistry, 1991
- Differentiation of EC cells in vitro by the fluorescent dye Hoechst 33342Experimental Cell Research, 1990
- DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cellsBiochemistry, 1989
- Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elementsNucleic Acids Research, 1989
- DNA as a target for drug actionTrends in Pharmacological Sciences, 1988
- Assignment of DNA binding sites for 4′,6-diamidine-2-phenylindole and bisbenzimide (Hoechst 33258). A comparative footprinting studyBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1988
- Binding of Hoechst 33258 to the minor groove of B-DNAJournal of Molecular Biology, 1987
- Effects of Hoechst 33258 on different cell cycle eventsExperimental Cell Research, 1983
- Measurement of DNA synthesis by flow cytometryCytometry, 1981
- The pleiotropic effects of 33258-Hoechst on the cell cycle in Chinese hamster cells in vitroExperimental Cell Research, 1980